The FDA granted “emergency use authorization” to Cepheid, a California company that makes a rapid molecular test for the coronavirus. The turnaround time for Cepheid’s product is far shorter than for the tests being used, which are typically sent to centralized labs that may not return results for days..."
Saturday, March 21, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment